Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
7
INMB Quote, Financials, Valuation and Earnings
Last price:
$2.25
Seasonality move
:
-2.38%
Day range:
$2.05 - $2.36
52-week range:
$1.89 - $11.64
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1,061.01x
P/B ratio:
1.83x
Volume:
2.9M
Avg. volume:
5M
1-year change:
-76.27%
Market cap:
$54.3M
Revenue:
$14K
EPS (TTM):
-$1.93
Earnings Data
Next earnings date for INMB
Aug 01
2025
Most recent earnings per share
-$0.43
Beat by $0.03
(May 8/2025)
Consensus Estimate
-$0.46
(May 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
INMB Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.33 | -- |
| 08/01/2025 | Q2 | -- | -- | -- | -$0.39 | -- |
| 05/08/2025 | Q1 | -- | $50K | -$0.43 | -$0.46 | $0.03 |
| 03/27/2025 | Q4 | -- | -- | -$0.40 | -$0.53 | $0.13 |
| 10/31/2024 | Q3 | -- | -- | -$0.60 | -$0.49 | -$0.11 |
| 08/01/2024 | Q2 | $4.7K | -- | -$0.50 | -$0.62 | $0.12 |
| 05/09/2024 | Q1 | $14K | $14K | -$0.61 | -$0.52 | -$0.09 |
| 03/28/2024 | Q4 | $14.3K | $28K | -$0.47 | -$0.47 | -$0.00 |
| 11/01/2023 | Q3 | -- | -- | -$0.48 | -$0.40 | -$0.08 |
| 08/07/2023 | Q2 | -- | -- | -$0.36 | -$0.39 | $0.03 |
| 05/03/2023 | Q1 | -- | -- | -$0.36 | -- | -- |
| 03/02/2023 | Q4 | -- | -- | -$0.32 | -$0.50 | $0.18 |
| 11/02/2022 | Q3 | -- | -- | -$0.43 | -$0.53 | $0.10 |
| 08/03/2022 | Q2 | -- | -- | -$0.38 | -$0.48 | $0.10 |
| 05/05/2022 | Q1 | -- | -- | -$0.39 | -$0.60 | $0.21 |
| 03/03/2022 | Q4 | -- | -- | -$0.55 | -$0.55 | -- |
| 11/03/2021 | Q3 | -- | -- | -$0.55 | -$0.41 | -$0.15 |
| 08/04/2021 | Q2 | -- | -- | -$0.44 | -$0.34 | -$0.10 |
| 05/05/2021 | Q1 | -- | -- | -$0.32 | -$0.28 | -$0.05 |
| 03/04/2021 | Q4 | -- | -- | -$0.24 | -$0.28 | $0.04 |
| 11/05/2020 | Q3 | -- | -- | -$0.36 | -$0.17 | -$0.19 |
| 08/05/2020 | Q2 | -- | -- | -$0.20 | -$0.23 | $0.03 |
| 05/14/2020 | Q1 | -- | -- | -$0.19 | -$0.21 | $0.02 |
| 03/11/2020 | Q4 | -- | -- | -$0.22 | -$0.25 | $0.03 |
| 11/08/2019 | Q3 | -- | -- | -$0.28 | -$0.19 | -$0.09 |
| 08/12/2019 | Q2 | -- | -- | -$0.04 | -$0.20 | $0.16 |
| 05/15/2019 | Q1 | -- | -- | -$0.20 | -$0.19 | -$0.01 |
| 12/31/2018 | Q4 | -- | -- | -$0.17 | -$0.19 | $0.02 |
| 09/30/2018 | Q3 | -- | -- | -$0.14 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$0.55 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$0.25 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$0.04 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$0.03 | -- | -- |
INmune Bio Earnings Questions
-
How Much did INmune Bio Generate in Revenue Last Quarter?
INmune Bio reported $50K worth of top line sales in its most recent quarter.
-
Did INmune Bio Beat Earnings Last Quarter?
INmune Bio announced earnings per share of -$0.43 which represents a beat of analyst forecast a -$0.46 per share.
-
Is INmune Bio Profitable?
INmune Bio reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for INmune Bio EPS Next Year?
INmune Bio's earnings are forecast to decrease from -$2.11 per share to -$2.24 per share next year representing a decrease of -16.23%.
-
When is INmune Bio's Earnings Date?
INmune Bio's next earnings date is August 1, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
